Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04858932 · ClinicalTrials.gov registry record
Geriatric Anorexia Study
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 51
- Enrollment target
NCT04858932: Completed study, sponsored by Boston University.
NCT04858932 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04858932 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
Reduction in appetite and/or food intake among older individuals is referred to as anorexia of aging (AOA, also known as Geriatric Anorexia). AOA is linked with myriad comorbidities associated with aging, contributes significantly to adverse health consequences in old age, and has been used as a predictor of morbidity and mortality. The overall aim of this study is to assess the feasibility and burden of the proposed in-laboratory and out-of-laboratory assessments to study Geriatric Anorexia. This will be accomplished with the use of questionnaires as well as devices that evaluate movement, metabolism, body weight composition, glucose levels, and nutritional scale.
Primary Outcome
One GENEActiv watch will be used on one wrist and one around the waist at a sampling rate of 50 Hz to measure movement in the x, y, and z direction across the study period.
Interventions
- DEVICE Continuous Glucose Monitor
- DEVICE Wrist Actigraphy Device
- DEVICE Food Weight Scale
- DEVICE Smart Body Weight Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2021-12-15 |
What the finished NCT04858932 record still lists
NCT04858932 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Continuous Glucose Monitor is the first listed.
NCT04858932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04858932 about?
NCT04858932 is a clinical study titled "Geriatric Anorexia Study". Reduction in appetite and/or food intake among older individuals is referred to as anorexia of aging (AOA, also known as Geriatric Anorexia). AOA is linked with myriad comorbidities associated with aging, contributes significantly to adverse health consequences in old age, and has been used as a pre...
What is the current status of trial NCT04858932?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2021-04-27. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT04858932?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Wrist Actigraphy Device (DEVICE), Food Weight Scale (DEVICE), Smart Body Weight Scale (DEVICE).
Who is sponsoring clinical trial NCT04858932?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI